showed a trendp =0.058
Estrade et al evaluated OS and lymphopenia and showed a trend towards worse overall survival in those with <1 G/L at 3 months post treatment (median OS 17.3 vs 19.9 months, p =0.058) while seeing no association at the pretreatment time point. 8 These findings are fairly similar to our study, which did show a significant association between lymphopenia and OS at 3 months.